Back to search

Article

Randomized Crossover Clinical Trial of Nicotinamide Riboside and Coenzyme Q10 on Metabolic Health and Mitochondrial Bioenergetics in CKD

2024-08-23

Abstract excerpt

<h4>Background</h4> Mitochondria-driven oxidative/redox stress and inflammation play a major role in chronic kidney disease (CKD) pathophysiology. Compounds targeting mitochondrial metabolism may improve mitochondrial function, inflammation, and redox stress; however, there is limited evidence of their efficacy in CKD. <h4>Methods</h4> We conducted a randomized, double-blind, placebo-controlled crossover trial com...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e27ae19-db72-52c9-8ba2-2d053d4b97e6
DOI
10.1101/2024.08.23.24312501
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Randomized Crossover Clinical Trial of Nicotinamide Riboside and Coenzyme Q10 on Metabolic Health and Mitochondrial Bioenergetics in CKDDOI 10.1101/2024.08.23.24312501
Select a neighboring publication to make it the new centre.